Internalization of obligate intracellular bacteria belonging to the genus Rickettsia by eukaryotic cells requires participation of both the parasitized host and the microorganism. The term "induced phagocytosis" has been used specifically to describe the entry of Rickettsia prowazekii, although a similar mechanism is likely for R. rickettsii. A role for a phospholipase in the internalization process has been proposed for both of these organisms, with the strongest supporting evidence provided for R. prowazekii. Despite general acceptance of the notion that phospholipase activity is involved in the internalization process of these bacteria, the origin of the enzyme is not known. The results of the study presented here, which used R. rickettsii and Vero cells, suggest that a rickettsial phospholipase, rather than a host cell phospholipase, mediates internalization of the organism. This conclusion is based upon results which show that pretreatment of R. rickettsii, but not of host cells, with a specific chemical inhibitor of phospholipase, and also antiserum to this enzyme, significantly reduces uptake of the organism and its ability to cause plaque formation.
The cell penetration mechanism utilized by members of the genus Rickettsia to enter nonphagocytic eukaryotic cells is not completely understood. Strong evidence has been provided by Winkler and Miller (13, 14) that suggests the involvement of phospholipase A in the internalization of Rickettsia prowazekii by susceptible host cells. These researchers have also reported that phospholipase activity is associated with hemolysis of sheep and human erythrocytes by this organism (12) . In both the penetration of nucleated cells and the lysis of erythrocytes, it remains unclear, however, whether the phospholipase is elaborated by the rickettsiae or whether it is a host cell enzyme that is activated upon contact of the organism with the plasma membrane of the cell.
To further strengthen the apparent role of phospholipase in rickettsia-host cell interactions, Winkler and Daugherty (11) have also suggested that this enzyme is associated with the exit of rickettsiae from infected cells. This hypothesis was based on the ability of the researchers to demonstrate a significantly increased rate of hydrolysis of fatty acid in L-929 cells infected with R. prowazekii that began shortly after internalization of the rickettsiae and continued throughout the course of the infection cycle.
The proposed role for phospholipase-associated entry of rickettsiae into cells has not been limited to R. prowazekii. Walker et al. (8) have carried out studies in which they have shown that the phospholipase inhibitor phentermine, when introduced into an agarose overlay, reduced plaque formation by R. rickettsii in primary chicken embryo fibroblasts and Vero cells. Although the actual effects of the drug on the kinetics of uptake and growth of R. rickettsii were not reported, these investigators suggested that the reduction in plaque formation was due to inhibition of internalization of the organism by this compound.
As a result of the studies with R. prowazekii and R.
rickettsii, there appears to be reasonably good evidence in support of the notion that phospholipase is an important enzyme for rickettsial entry into cells. Furthermore, if the source of its activity can eventually be shown to be rickettsia associated, then this enzyme could be considered an essential virulence factor in the pathogenesis of these obligate intracellular bacterial parasites. However, the source of the phospholipase activity remains unclear.
The enzymatic action of phospholipase has recently been proposed as the mechanism of cell entry for one specific protozoan parasite and the cytolytic reaction of another (4, 6) . Studies by Saffer et al. (6) , using inhibitors of phospholipase A2 and antiserum to this enzyme, have shown that phospholipase plays a key role in the penetration of Toxoplasma gondii into human fibroblastic cells. Moreover, their studies provide convincing evidence that internalization of this parasite occurs through a phospholipase activity associated with the parasite and not with the host cell. We took a similar experimental approach in the study reported here, to (10) . The rickettsial seeds used in the experiments described below had PFU titers between 1 x 107 and 2 x 107/ml. A 10-6 final dilution of the seed stock was used for plaque assays, and a dilution of 10-2 was used for growth studies.
Studies with the phospholipase A2 inhibitor p-BPB. Both the organism, R. nckettsii, and the host cells, Vero cells, were pretreated with several concentrations of p-BPB, and the effects were assessed by examining the subsequent uptake and spread of R. rickettsii in the Vero cells and by the capacity of the organism to form plaques on monolayer cultures of these cells. Parallel studies also included posttreatment of infected cells withp-BPB (Sigma Chemical Co., St. Louis, Mo.) and measurement of its effect on spread and plaque formation. A stock solution ofp-BPB, 2.78 mg/10 ml, was prepared in warm 95% ethanol, and appropriate dilutions were made so that the rickettsiae and cells could be treated with 10, 5, 1, and 0 p,M concentrations of the inhibitor. For pretreatment of the rickettsiae in the plaque assay procedure, the rickettsial seed was diluted to either i0-' or 10-6 times its original titer. The organisms were then treated at these dilutions with the appropriate concentrations ofp-BPB for 15 min in an ice bath. The rickettsiae at the 10-6 dilution were added directly to Vero cells in Costar 12-well plates and incubated for 1.5 h at 37°C. Those microorganisms similarly treated at a 10-4 dilution with p-BPB were subsequently diluted to 10-6 in DMEM and then added to the Vero cells as described above. The purpose of treating the rickettsiae at a 10-4 dilution was to effectively dilute the p-BPB after treatment of the rickettsiae so that the concentration of any unbound p-BPB during infection of the Vero cells would be negligible. Following incubation, the medium was removed and fresh DMEM-10% FBS containing agarose added to each well. After 6 days, the plaques that formed were stained with 3% neutral red prepared in DMEM and counted, and their sizes (diameters) were measured with a Bausch & Lomb micrometer.
Monolayer cultures of Vero cells also were similarly pretreated prior to infection with the same concentrations of p-BPB, except that the treatments were carried out at 37°C in a CO2 incubator. Following treatment, the cells were washed with Hanks balanced salt solution and infected with a 10-6 dilution of R. rickettsii for 1.5 h and plaque assays were performed as described above. In some experiments, cultures which already had been infected with R. rickettsii for 1.5 h were also treated with p-BPB, which was added to the agarose overlay, and in other experiments, we tested the effects of multiple additions of the inhibitor on plaque formation by addingp-BPB at the same concentrations to the agarose overlay on three consecutive days after initial treatment of the rickettsiae.
For comparison, normalization of the p-BPB plaque data and the plaque data for the antiphospholipase serum described below was carried out as follows: the highest numerical values obtained within a specified set of treatment conditions were routinely set at 100%, and the corresponding populations were normalized to that value. All of the normalized values were combined, and a mean and standard error of the mean (SEM) were calculated.
To ensure that the ethanol used to prepare the dilutions of p-BPB had no effect by itself on the development of plaques in these experiments, the same concentrations of ethanol (without p-BPB) were used as controls for pretreatment of both the rickettsiae and the Vero cells and for posttreatment of infected Vero cells. There was no inhibitory effect at any of the concentrations of ethanol used.
For studies on the effect of p-BPB on the growth of R. rickettsii, the microorganisms were either pretreated with appropriate concentrations of the inhibitor in an ice bath, or for posttreatment, the Vero cell cultures were treated with p-BPB after they were exposed to R. rickettsii for 1.5 h at 37°C. Briefly, 10-2 dilutions of the seed stock of R. rickettsii were incubated for 15 min on ice with 10, 5, 1, and 0 ,uM p-BPB. The rickettsiae were added to Vero cells growing on coverslips and incubated for 1.5 h, and samples were removed at 0, 24, 48, and 72 h. In some experiments, p-BPB was also added after 24 and 48 h to determine the effects of multiple treatments with the inhibitor on the kinetics of rickettsial infection. Cells on the coverslips were stained by the method of Gimenez (2) . A minimum of 200 cells per time point and condition were counted to determine the average number of rickettsiae per infected cell and the percentage of cells infected.
To test its stability and whetherp-BPB could be effective over an extended period of time under typical cell culture conditions, p-BPB, at the concentrations used in the experiments, was added to complete culture medium alone and incubated for 24 h at 37°C prior to use on the rickettsiae and Vero cells.
To examine whether a population of rickettsiae once treated with p-BPB is permanently inhibited from internalization, the organisms were pretreated with the inhibitor for 15 min on ice as described above and then washed twice with phosphate-buffered saline by centrifugation in an Eppendorf microcentrifuge for 10 min. The respective rickettsial pellets were resuspended in growth medium and diluted, and plaque assays were performed.
Studies with antiphospholipase serum. Lyophilized antiserum to 0. hannah (king cobra) venom prepared in a horse was obtained from Sigma and rehydrated, as directed by the supplier, in sterile water. Normal horse serum (mycoplasma tested) was obtained from Paragon Biotech, Inc., Baltimore, Md. Experiments with the anticobra venom were carried out to determine its effects on the uptake and growth of R. nickettsii in Vero cells by light microscopic and plaque assay techniques (2, 10) . In some experiments, the antiserum and normal horse serum were heat inactivated at 56°C for 30 min. In pretreatment studies for plaque assays, the rickettsiae were incubated with dilutions of the antiserum (1:20, 1:10, and 1:5) or normal horse serum prepared in DMEM with 10% FBS for 15 min in an ice bath. The rickettsiae were added to monolayer cultures of Vero cells and incubated for 1.5 h at 37°C. Following incubation, the culture medium was removed, the cells were washed twice with Hanks balanced salt solution, fresh DMEM with 10% FBS and agarose was added, and the cultures were incubated for 6 days as described above. Samples of the pretreated rickettsiae also were added to Vero cells growing on coverslips to determine the effects of the antiserum on uptake and spread of the rickettsiae. Samples were removed at 1.5 h to determine uptake and at 24 and 48 h to examine the effect of the antiserum on the spread of the organism in the cultures as measured by an increase in the percentage of cells infected. Infected Vero cell cultures were also posttreated with identical dilutions of antiserum at 1.5 h postinfection with R.
rickettshi to measure this same parameter. In these experi- at 24 h between treated and untreated cultures and no difference at 48 h (Fig. 3) . Two subsequent treatments of R. rickettsii-infected cells at 24 and 48 h postinfection with p-BPB had no detrimental or synergistic effect on the kinetics of rickettsial infection.
To measure the effects of p-BPB on plaque formation by R. rickettsii, rickettsiae were pretreated with this compound as described in Materials and Methods and added to monolayers of Vero cells. Controls included no treatment with p-BPB, pretreatment of the cells with the same concentrations of p-BPB used to treat the rickettsiae, and addition of p-BPB to the cultures 1.5 h after initial infection of the cells. The number of plaques formed under the preceding treatment conditions were normalized against the number of plaques formed when there was no treatment of the cells or the rickettsiae. All of the normalized values were combined, and a percent mean and SEM were calculated. Figure 4 shows the results of these experiments. When the Vero cells were pretreated with p-BPB or when p-BPB was added to the cultures 1.5 h after infection, there was no effect on the capacity of R. rickettsii to form plaques. However, when the rickettsiae were pretreated with 5 and 10 ,uM concentrations of this compound at a 10-6 dilution of the rickettsial seed stock, there was a significant reduction in the number of Fig. 1 , or the rickettsiae were treated at a dilution of 10-4, further diluted to 106, and then added directly to confluent Vero cells in 12-well plates. After 1.5 h, the inoculum was removed and fresh growth medium containing agarose was added to each well. Plaque plates were incubated at 37°C and stained after 6 days with 3% neutral red. In some experiments, the Vero cells were pretreated with p-BPB for 15 min at 37°C prior to infection with R. rickettsii, and in others, Vero cells were treated 1.5 h after infection by adding the inhibitor to the agarose overlay. The data represent a minimum of six experiments per condition and are expressed as the means ± the SEM. formed, and at 10 pM p-BPB, plaque formation was totally inhibited. When rickettsiae were pretreated at a dilution of 10-' and then subsequently diluted to 10-6 before exposure to Vero cells, there was also a significant but less dramatic effect on the ability of the organisms to form plaques. At a concentration of S p,M p-BPB, there was approximately a 30% decrease in the number of plaques formed, and at 10 p,M there was a 70% decrease. It appears that the increased effectiveness of p-BPB upon rickettsiae treated at a dilution of 10-6 was due to the increased time of exposure to the inhibitor, since it remained in constant contact with the organisms, unlike those organisms treated at a dilution of 10'. Sincep-BPB did not inhibit the growth of rickettsiae once they were internalized, the reduction in plaque formation probably could be attributed to the initial inhibition by p-BPB of uptake of rickettsiae. p-BPB was ineffective in inhibiting internalization and plaque formation when incubated by itself for 24 h at 37°C prior to use, confirming its relative instability in solution (6a) . This also would explain, in part, its apparent inability to affect the subsequent growth and spread of R rickettsii over the course of the experiments. When additional doses of p-BPB were added to the agarose overlay on three consecutive days after initial pretreatment of the organisms, the number of plaques formed was the same as with a single dose of the inhibitor, suggesting thatp-BPB is most effective when used to prevent initial uptake of the organisms by cells. Whilep-BPB was effective in reducing the number of plaques caused by R. nckettsii in Vero cells under the above-described conditions, the sizes of the plaques were not changed.
To address the possibility of toxicity ofp-BPB for rickettsiae, we pretreated the organisms with p-BPB on ice for 15 min and then washed them twice by centrifugation before diluting and adding them to Vero cells. We were able to reduce the inhibition caused byp-BPB by about 50%; that is, we were able to increase by this percentage the number of plaques formed compared with those formed by rickettsiae that were not washed. The fact that we could wash the rickettsiae and restore a certain amount of infectivity suggests that inhibition is more likely due to blockage of internalization of the organism than to killing of the rickettsiae prior to entry.
Treatment ofR. rickettsii and R. rickettsii-infected Vero cells with antiphospholipase serum and its effect on internalization of the organism, kinetics of infection, and plaque formation. Antiserum to the venom of the king cobra, 0. hannah, was used to test its effectiveness in neutralizing the phospholipase activity presumed to be required for entry of R.
rickettsii into host cells. Pretreatment ofR. rickettsii with the antiserum resulted in a significant reduction in the number of organisms internalized by Vero cells (Fig. 5) . At a 1:20 dilution of the antiserum, there was a 50% reduction, and at 1:5 there was about a 65% reduction in the average number of rickettsiae per infected cell at 1.5 h after exposure of the cells to the organism. The effects of pretreatment of the rickettsiae with antiserum on intercellular spread of the organism showed no significant difference from the untreated controls after 48 h (Fig. 6) . However, when antiserum was added to infected cultures at 1.5 h after they were exposed to rickettsiae and allowed to remain in the culture medium, there was a significant effect on the spread of the organism as measured by the percentage of cells infected (Fig. 7) . After 48 h, the 1:20 and 1:10 antiserum dilutions showed 30 and 40% reductions, respectively, while a 1: fected cells. Normal horse serum, when used at similar dilutions and substituted for the antiserum in the culture medium, had no effect on the growth kinetics of the organism.
In the plaque assay system, three treatment regimens were employed (Fig. 8) . When Vero cells were pretreated with antiserum, there was no reduction in the number of plaques formed. When rickettsiae were pretreated with the antise- rum, there was a 10% reduction in the number of plaques at a 1:10 dilution and a 35% reduction at a 1:5 dilution of the antiserum. The most dramatic results, however, were seen when antiserum was added to cells already infected with R. nckettsii. At a 1:10 dilution of the antiserum, there was a 45% reduction in the number of plaques formed in Vero cells, and at a dilution of 1:5, plaque formation was completely inhibited. As was the case withp-BPB, the number of plaques formed was reduced but the size of the plaques was not significantly changed in the presence of antiserum. Normal horse serum, when substituted for antiserum at the same dilutions, had no effect on plaque formation. DISCUSSION Internalization of rickettsiae by nonphagocytic host cells is not completely understood. It is generally recognized that both the host cell and the microorganism must participate for internalization to take place (1, 9) . Several years ago, Winkler and Miller (13, 14) proposed that these obligate intracellular bacterial parasites enter cells through a mechanism that involves a phospholipase A activity. This hypothesis was based on the demonstration that host cells exposed to large numbers of R. prowazekii organisms (50 or more per cell) release considerable amounts of lysophosphatides and free fatty acids into the cell culture medium. The release of these membrane components was also demonstrable in the hemolysis of erythrocytes, which was considered by these researchers to be an abortive attempt by the rickettsiae to parasitize the erythrocytes (12) . These reports establish with some confidence a role for this enzyme in the entry of R.
prowazekii into susceptible host cells. What remains unclear about the internalization process, however, is the origin of the phospholipase activity. Whether the enzyme originates from the organism itself or is a latent host enzyme activated upon contact of the rickettsiae with the host cell membrane is still not known.
Available evidence that phospholipase is involved in the internalization of R. nckettsii, the etiological agent of Rocky Mountain spotted fever, is not as convincing. Walker et al. (8) have shown that when the phospholipase inhibitor phentermine is incorporated into a standard plaque assay system there is a dose-dependent reduction in the number of plaques formed in either chicken embryo or Vero cells. While this is suggestive of a specific effect mediated by phentermine, these studies do not rule out the possibility that phentermine was directly toxic to the organism and that the inhibition of internalization was nonspecific.
In the series of experiments presented here, we provide strong evidence for a role for phospholipase in the entry of R. rickettsii into eukaryotic cells which takes into account the specificity of the inhibition of rickettsial entry and the potential toxicity of specific inhibitors of phospholipase activity on the host cell and the organism itself. We utilized p-BPB, an irreversible inhibitor of phospholipase A2, and also antiserum to this enzyme to demonstrate their capacity to prevent infection of Vero cells as measured by uptake of the organism, spreading of the organism to adjacent cells in the culture, and injury to the host cells as measured by the plaque assay technique. In other systems, p-BPB has been shown to rapidly inactivate both cobra venom phospholipase (5) and porcine pancreatic phospholipase A2 (7) by alkylation of histidine residues at the active site on the enzyme molecule. In a study by Volwerk et al. (7) (7) . Thus, the specificity of this compound has been well documented.
Studies with p-BPB demonstrated that this compound has the capacity to prevent internalization of R. nickettsii in a dose-dependent manner when the organisms are pretreated for a short time prior to exposure to Vero cells. In a recent study (6) , similar inhibition of internalization of Toxoplasma gondii into human foreskin fibroblasts was found when this parasite was pretreated with p-BPB and antiserum to phospholipase A2. To determine whether p-BPB is toxic to intracellular R. nckettsii, this compound was added in single and multiple doses to the culture medium and allowed to remain throughout the course of some experiments. Our results showed that it did not inhibit intracellular growth of the organisms or the ability of the organisms to spread to adjacent cells. Although the lack of a long-term effect of p-BPB could have been due to gradual breakdown of the compound in solution, in the short term, it appears to be capable of acting specifically to inhibit internalization of R. rickettsii. While we cannot totally rule out the possibility of some toxicity of p-BPB for extracellular rickettsiae, the ability to restore some of the plaque-forming ability of the rickettsiae by washing them after treatment with this compound suggests specific inhibition rather than killing of the organism. Furthermore, it is interesting that the 10 ,uM concentration ofp-BPB which effectively reduced rickettsial internalization by about 50% in our experiments is also the 50% inhibitory concentration for phospholipase A2 from rabbit peritoneal polymorphonuclear leukocyte extracts (3) .
The plaque data obtained with p-BPB also tend to verify the results described above. Pretreatment of the Vero cells withp-BPB or addition ofp-BPB to cultures already infected with R. rickettsii had no effect on plaque formation. However, pretreatment of the organism with p-BPB prior to cell infection resulted in a very significant reduction in the number of plaques formed. Ultimately, at 10 ,uM p-BPB, when the rickettsiae were treated directly at a 10-6 dilution, plaque formation was totally inhibited, demonstrating the importance of inhibition of internalization in the prevention of cell injury. Even when the rickettsiae were treated at a dilution of 10' for only 15 min and then diluted to 10-6, plaque formation was reduced by 70%.
p-BPB apparently has no effect on the phospholipase A2 activity of intact cells, such as rabbit peritoneal polymorphonuclear leukocytes, but does inhibit this enzyme in sonicates and acid extracts of these cells (3) . This observation implies that p-BPB does not gain access to the phospholipase A2 of intact eukaryotic cells. Thus, rickettsial internalization would not likely be blocked by an inhibitor which is inaccessible to the enzyme putatively responsible for rickettsial uptake. This implies, but does not conclusively prove, that a phospholipase exposed on the external surface of the rickettsia rather than on the host cell is involved in entry of the organism.
Antiserum to phospholipase was also effective in blocking internalization of R. rickettsii when the organisms were pretreated for as short a time as 15 min. The effects of pretreatment, however, were noticeable only at the initial internalization stages of infection. By 48 h postinfection, the percentages of infected cells were the same for rickettsiae pretreated with antiserum and those that were untreated. Since the pretreated inoculum was removed after 1.5 h together with most of the residual unbound antibody, this result was not unexpected. However, when the antiserum was added to the culture at 1.5 h postinfection with R.
rickettsii and allowed to remain until termination of the experiment, the kinetics of infection were altered considerably. The continued presence of the antiserum in the culture medium significantly reduced the intercellular spread of the organisms and suggested that rickettsiae exiting infected cells subsequently were prevented from infecting previously uninfected cells. The contrast between the findings on the abilities of antiserum and p-BPB to inhibit internalization of R. rickettsii for an extended time presumably is due to the stability of the antibodies in the antiserum versus the instability ofp-BPB. p-BPB was able to inhibit plaque formation only when the rickettsiae were pretreated with the compound. Antiserum to phospholipase A, on the other hand, was effective in significantly reducing plaques when the rickettsiae were pretreated and in totally blocking plaque formation when it remained in the culture medium for the entire period of the plaque assay.
The results of these experiments extend the preliminary studies by Walker et al. (8) , which suggest that phospholipase is important in the penetration and subsequent injury of cells by R. nickettsii. Furthermore, they strengthen a generalization that this enzyme is the mechanism used by members of the genus Rickettsia to invade nonphagocytic cells. The results of our study suggest, but do not conclusively prove, that the phospholipase activity associated with internalization of R. nckettsii lies directly with the infecting microorganism rather than with the host cell. The evidence in support of this concept is based on the ability of antiphospholipase agents to block internalization only when the organisms, not the host cells, are pretreated. From a mechanistic standpoint, this seems more feasible since the likelihood that pretreatment of the organism with inhibitors of phospholipase subsequently results in inhibition of activation of a host cell phospholipase is small. If the latter were to occur, the unlikely assumption would have to be made that blockage of one or more epitopes on an exposed rickettsial phospholipase molecule by eitherp-BPB or antiserum would be sufficient to prevent activation of a host phospholipase by the organism. While rickettsial activation of a host phospholipase, perhaps, should not be summarily dismissed as a potential mechanism of entry of the organism, the evidence presented here seems not to support a role for a host enzyme. Definitive evidence that the phospholipase originates from these microorganisms could be provided by isolation and cloning of a specific rickettsial gene(s) involved in the internalization process.
